Interpace Biosciences (IDXG) Reports Q2 EPS of $0.48

Interpace Biosciences (OTC: IDXG) reported Q2 EPS of $0.48, Revenue for the quarter came in at $12 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• Benchmark initiates Synopsys, Cadence with Buy ratings on AI-driven EDA outlook
• Regions Financial (RF) call put ratio 41 calls to 1 put into quarter results
• Natural Gas Inventory 41 bcf vs 41 bcf Expected